LOXAPINE (loxapine succinate)
ANTIPSYCHOTICS · SCHIZOPHRENIA
ELITE LABORATOR
Drug class
Antipsychotic Dopamine/Serotonin Antagonists
Antipsychotic dopamine and serotonin antagonists, commonly classified as second-generation or atypical antipsychotics, are a major therapeutic class of psychotropic medications. Read more about Antipsychotic Dopamine/Serotonin Antagonists
11 drugs in this class 11 manufacturers
Drugs in Antipsychotic Dopamine/Serotonin Antagonists
LOXAPINE (loxapine succinate)
ANTIPSYCHOTICS · SCHIZOPHRENIA
REMEDYREPACK, I
Filter & compare in the drug finder →
Opens the drug finder with Antipsychotic Dopamine/Serotonin Antagonists preselected. Add indication or manufacturer filters there.
Antipsychotic dopamine and serotonin antagonists, commonly classified as second-generation or atypical antipsychotics, are a major therapeutic class of psychotropic medications.
They exert their therapeutic effect primarily through concurrent antagonism of central dopamine D2 and serotonin 5-HT2A receptors, an dual-target profile that modulates dopaminergic neurotransmission in mesolimbic pathways while reducing the risk of extrapyramidal motor symptoms compared to first-generation agents.
Clinically, these agents serve as fundamental pharmacotherapies for schizophrenia, schizoaffective disorder, and acute manic or mixed episodes associated with bipolar disorder, and they frequently function as adjunctive therapies for treatment-resistant major depressive disorder.
-
nih.gov
Antipsychotic dopamine and serotonin antagonists, commonly classified as second-generation or atypical antipsychotics, are a major therapeutic class of psychotropic medications They exert their therapeutic effect primarily through concurrent antagonism of central dopamine D2 and serotonin 5-HT2A receptors, an dual-target profile that modulates dopaminergic neurotransmission in mesolimbic pathways while reducing the risk of extrapyramidal motor symptoms compared to first-generation agents
-
nih.gov
Antipsychotic dopamine and serotonin antagonists, commonly classified as second-generation or atypical antipsychotics, are a major therapeutic class of psychotropic medications Clinically, these agents serve as fundamental pharmacotherapies for schizophrenia, schizoaffective disorder, and acute manic or mixed episodes associated with bipolar disorder, and they frequently function as adjunctive therapies for treatment-resistant major depressive disorder
-
nih.gov
They exert their therapeutic effect primarily through concurrent antagonism of central dopamine D2 and serotonin 5-HT2A receptors, an dual-target profile that modulates dopaminergic neurotransmission in mesolimbic pathways while reducing the risk of extrapyramidal motor symptoms compared to first-generation agents
-
nih.gov
They exert their therapeutic effect primarily through concurrent antagonism of central dopamine D2 and serotonin 5-HT2A receptors, an dual-target profile that modulates dopaminergic neurotransmission in mesolimbic pathways while reducing the risk of extrapyramidal motor symptoms compared to first-generation agents
-
nih.gov
Clinically, these agents serve as fundamental pharmacotherapies for schizophrenia, schizoaffective disorder, and acute manic or mixed episodes associated with bipolar disorder, and they frequently function as adjunctive therapies for treatment-resistant major depressive disorder
-
nih.gov
Clinically, these agents serve as fundamental pharmacotherapies for schizophrenia, schizoaffective disorder, and acute manic or mixed episodes associated with bipolar disorder, and they frequently function as adjunctive therapies for treatment-resistant major depressive disorder
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.